Abstract
DNA double-strand breaks (DSBs) are a common form of DNA damage and double-strand break rejoining is a fundamental mechanism of genome protection to prevent chromosomal fragmentation, translocation and deletions. DSBs may be induced by exogenous agents, such as ionizing radiation, but also occur spontaneously during cellular processes e.g. in the rearrangement of gene segments during V(D)J [variable (V), diversity (D), joining (J)] recombination. The ge-nomic instability resulting from incorrectly repaired DSBs can lead to carcinogenesis, while unrepaired may carry on even to cell death. To repair this potentially lethal damage cells developed several different types of repair act on the DSBs e.g. homologous recombination repair (HRR), non-homologous DNA end joining (NHEJ), and single-strand annealing (SSA).The most essential in mammalian cells is NHEJ, whereas HRR and SSA significantly contributes to DSBs repair in lower eukaryotes. At least six distinct proteins are known to be required for NHEJ, i ncluding Ku70, Ku80, DNA-PKcs, XRCC4, DNA ligase IV, and Artemis. In this review we highlight classical and up-to-date aspects and present understanding of the molecular mechanisms of NHEJ in the maintenance of genome integrity.
Keywords: Non-homologous DNA end joining, NHEJ, DNA double-strand breaks repair, DNA-PK, DNA-PKcs, Ku70, Ku80, XRCC4, ligase IV, Artemis
Current Genomics
Title: Double-Strand Breaks Repair by Non-Homologous DNA End Joining in Mammalian Cells
Volume: 7 Issue: 5
Author(s): Mariusz Malinowski and Elzbieta Pastwa
Affiliation:
Keywords: Non-homologous DNA end joining, NHEJ, DNA double-strand breaks repair, DNA-PK, DNA-PKcs, Ku70, Ku80, XRCC4, ligase IV, Artemis
Abstract: DNA double-strand breaks (DSBs) are a common form of DNA damage and double-strand break rejoining is a fundamental mechanism of genome protection to prevent chromosomal fragmentation, translocation and deletions. DSBs may be induced by exogenous agents, such as ionizing radiation, but also occur spontaneously during cellular processes e.g. in the rearrangement of gene segments during V(D)J [variable (V), diversity (D), joining (J)] recombination. The ge-nomic instability resulting from incorrectly repaired DSBs can lead to carcinogenesis, while unrepaired may carry on even to cell death. To repair this potentially lethal damage cells developed several different types of repair act on the DSBs e.g. homologous recombination repair (HRR), non-homologous DNA end joining (NHEJ), and single-strand annealing (SSA).The most essential in mammalian cells is NHEJ, whereas HRR and SSA significantly contributes to DSBs repair in lower eukaryotes. At least six distinct proteins are known to be required for NHEJ, i ncluding Ku70, Ku80, DNA-PKcs, XRCC4, DNA ligase IV, and Artemis. In this review we highlight classical and up-to-date aspects and present understanding of the molecular mechanisms of NHEJ in the maintenance of genome integrity.
Export Options
About this article
Cite this article as:
Malinowski Mariusz and Pastwa Elzbieta, Double-Strand Breaks Repair by Non-Homologous DNA End Joining in Mammalian Cells, Current Genomics 2006; 7 (5) . https://dx.doi.org/10.2174/138920206778604386
DOI https://dx.doi.org/10.2174/138920206778604386 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Micro-Aggregation Algorithm Based on Density Partition Method for Anonymizing Biomedical Data
Current Bioinformatics Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma
Medicinal Chemistry Influence of Polymer Molecular Weight on in-vitro Characteristics and Cytotoxicity of Fulvestrant Loaded Nanoparticles
Current Drug Therapy Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Gene Delivery for Cancer Therapy
Current Drug Delivery FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA
Current Pharmaceutical Design Bisphosphonates and Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial
Reviews on Recent Clinical Trials Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Redox mechanisms in pathological angiogenesis in the retina: roles for NADPH oxidase
Current Pharmaceutical Design Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
Current Cancer Drug Targets Structurally Unprecedented Metabolites from Marine Sponges
Current Organic Chemistry Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview
Current Drug Metabolism Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry